Cite
HARVARD Citation
He, Y. et al. (2019). The effects of licogliflozin, a dual SGLT1/2 inhibitor, on body weight in obese patients with or without diabetes. Diabetes, obesity & metabolism. 21 (6), pp. 1311-1321. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
He, Y. et al. (2019). The effects of licogliflozin, a dual SGLT1/2 inhibitor, on body weight in obese patients with or without diabetes. Diabetes, obesity & metabolism. 21 (6), pp. 1311-1321. [Online].